Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Meliha C Kapetanovic; Lars Erik Kristensen; Tore Saxne; Teodora Aktas; Andreas Mörner; Pierre Geborek

doi:10.1186/ar4427

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Meliha C Kapetanovic, Lars Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner, Pierre Geborek

Reumatologi och molekylär skelettbiologi

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

169 Nedladdningar (Pure)

Sammanfattning

An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

Originalspråk	engelska
Artikelnummer	R2
Tidskrift	Arthritis Research and Therapy
Volym	16
Nummer	1
DOI	https://doi.org/10.1186/ar4427
Status	Published - 2014

Ämnesklassifikation (UKÄ)

Reumatologi och inflammation

Tillgång till dokument

10.1186/ar4427

BMC__Kapetanovic_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24383620?dopt=Abstract

Citera det här

@article{e28af2a419f642929285830f38d894e5,

title = "Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.",

abstract = "An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix{\textregistered}) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).",

author = "{C Kapetanovic}, Meliha and Kristensen, {Lars Erik} and Tore Saxne and Teodora Aktas and Andreas M{\"o}rner and Pierre Geborek",

year = "2014",

doi = "10.1186/ar4427",

language = "English",

volume = "16",

journal = "Arthritis Research & Therapy",

issn = "1478-6354",

publisher = "BioMed Central (BMC)",

number = "1",

}

TY - JOUR

T1 - Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

AU - C Kapetanovic, Meliha

AU - Kristensen, Lars Erik

AU - Saxne, Tore

AU - Aktas, Teodora

AU - Mörner, Andreas

AU - Geborek, Pierre

PY - 2014

Y1 - 2014

N2 - An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

AB - An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).

U2 - 10.1186/ar4427

DO - 10.1186/ar4427

M3 - Article

C2 - 24383620

SN - 1478-6354

VL - 16

JO - Arthritis Research & Therapy

JF - Arthritis Research & Therapy

IS - 1

M1 - R2

ER -

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Sammanfattning

Ämnesklassifikation (UKÄ)

Tillgång till dokument

Fingeravtryck

Citera det här